Internet Stroke Center Home Stroke Education for Clinicians & Students
 

Patients & Families   Health Professionals   Clinical Trials   About   Home 


Search the ISC 
Search the Web
 Stroke Education
Section Home
Glossary of
Neurological Terms

 Stroke Management
Thrombolytic Case Management Series
CT Learning Tool
Evaluation & Diagnosis
Stroke Care for EMT's & Paramedics
Management of Oral Anticoagulant Therapy
 Brain Anatomy
Anatomy of the Brain
Blood Vessels of the Brain
Pathogenesis & Pathophysiology
 Brain Imaging
Neurology Image Library
CT & MRI Criteria for Infarction & Hemorrhage
Guide to Imaging Techniques
MRI Compared to CT
 Stroke Facts
Epidemiology of Stroke
Stroke Risk Factors
Types of Stroke


Part One: Warfarin Dosing Guidelines

Warfarin Dosing in Elderly Patients

 

Mean Warfarin Daily Dose

Patient Age

<50

50-59

60-69

70-79

>80

Gurwitz, et al,  1992
(n=530 patients total study)

6.4

5.1

4.2

3.6

ND

James, et al,  1992
(n=2305 patients total study)

6.1

5.3

4.3

3.9

3.5

(Increasing age has been associated with an increased response to the effects of warfarin.)

References:
Gurwitz JH, et al. Ann Int Med 1992; 116(11): 901-904
James AH, et al. J Clin Path 1992; 45: 704-706

  

Notes:

This slide summarizes the results of two studies demonstrating the inverse relationship between mean warfarin dosage requirements and increasing age.

The elderly require a lower dose of warfarin to achieve the same level of therapeutic effectiveness.

 

Back

Contents

Next

 

About this presentation:

The content of these pages is from a presentation called  "Management of Oral Anticoagulant Therapy: Principles & Practice," prepared by the American Heart Association's Post-Graduate Education Committee of the Council on Clinical Cardiology.  Supported by an educational grant from DuPont Pharmaceuticals.

Authors: Jack Ansell, M.D., Jack Hirsch, M.D., Nanette K. Wenger, M.D.

Data current as of October 1999.

Endorsed by the Anticoagulation Forum and the American Heart Association Council on Atherosclerosis, Thrombosis, and Vascular Biology.

 

The entire PowerPoint presentation is available from the American Heart Association.

 

 

This site is a non-profit, educational service of Washington University School of MedicineInternet Stroke Center at Washington University:
TOP | HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997 - 2007 Internet Stroke Center. All rights reserved.

The information in this web site is not a substitute for medical advice or treatment.
Consultation with your doctor or health care professional is recommended.